| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.059 | 0.3 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.3 |